|
Information For:
|
Nefazodone Hydrochloride: Notice of Intent to ReviseDate Posted: March 20, 2009 In accordance with section 9.05(c) of the Rules and Procedures of the Council of Experts, this is to provide notice that the USP 2005-2010 Monograph Development-Psychiatrics and Psychoactives Expert Committee (MD-PP) intends to revise the Nefazodone hydrochloride monograph based on comments received indicating that the current Identification test B for chloride counter ion cannot be successfully performed. It is proposed to change the solvent for the Nefazodone hydrochloride from water to methanol due to the slightly soluble nature of drug substance in water. It is anticipated that the proposed revisions will be published in Pharmacopeial Forum 35(3) [May-June 2009] as a proposed Interim Revision Announcement pursuant to section 9.02(b) of the Rules and Procedures. In the absence of any adverse comments, the revision will be published as final in Pharmacopeial Forum 35(5) [Sept.-Oct. 2009] with an official date of October 1, 2009. What's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||